Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Assets (2016 - 2025)

Rockwell Medical's Assets history spans 16 years, with the latest figure at $57.1 million for Q4 2025.

  • For Q4 2025, Assets fell 3.48% year-over-year to $57.1 million; the TTM value through Dec 2025 reached $57.1 million, down 3.48%, while the annual FY2025 figure was $57.1 million, 3.48% down from the prior year.
  • Assets reached $57.1 million in Q4 2025 per RMTI's latest filing, down from $57.5 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $69.4 million in Q1 2021 to a low of $37.4 million in Q1 2022.
  • Average Assets over 5 years is $53.1 million, with a median of $53.5 million recorded in 2024.
  • Peak YoY movement for Assets: crashed 46.1% in 2022, then surged 39.41% in 2024.
  • A 5-year view of Assets shows it stood at $48.6 million in 2021, then decreased by 3.99% to $46.6 million in 2022, then rose by 11.88% to $52.2 million in 2023, then grew by 13.48% to $59.2 million in 2024, then dropped by 3.48% to $57.1 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Assets are $57.1 million (Q4 2025), $57.5 million (Q3 2025), and $52.6 million (Q2 2025).